A private brief on Jersey's regulatory opportunity in health, longevity and biotech. Access requires a password.

For access, contact Grace Parker directly.

49°13′N 2°08′WDivergent by design.
Jersey · A health-jurisdiction brief

Jersey.
Divergent by design.

The Channel Islands sit outside EU medicines regulation and outside the UK's NHS-shaped clinical framework. That is not a defect. It is the same regulatory freedom that made Jersey the finance jurisdiction it is today — and it is available, largely untouched, for health, longevity and biotech.

This site sketches what a considered use of that freedom could look like: domain by domain, with the legislative, economic and infrastructure work it would take.

2°15′W 2°10′W 2°05′W 49°15′N 49°12′N St Helier 49°11′N 2°06′W 05 km N ↑
Constitutional statusCrown Dependency
Regulatory domains7 examined
Framework horizon5–7 years
Impact at maturity£0.45–1.7B / yr
Who this is for

Two audiences, one argument.

The regulatory case and the commercial case are the same case. Jersey has the framework flexibility; what it needs is a coherent, credible design that the outside world can read and trust.

Jersey policy + government

A concrete framing of what regulatory divergence in health could unlock — with specific domains, licensing pathways and the infrastructure it depends on. Written to help make the case for a coherent health-jurisdiction strategy, not to prescribe one.

Biotech + research partners

A short read on why Jersey is a serious jurisdiction to do work that is slow, awkward or impossible elsewhere — small-cohort, n=1 and early-phase work where the framework itself is the enabler, not the price.

Contents

What sits on this site.

01 / Regulatory

The regulatory opportunity

Domain by domain: reproductive medicine, psychedelics, cannabis therapeutics, advanced therapeutics, trials, diagnostics, aesthetics. Where Jersey could sensibly diverge and what that would enable.

Read the opportunity →
02 / The Case

The political case

Why regulatory divergence in health fits Jersey's constitutional position, its policy track record and its next-decade strategic ambitions. What legislative work would be needed, and at what pace.

Read the case →
03 / Economic impact

Economic impact for Jersey

Aggregate revenue across the seven domains, adjacent-industry multipliers, and a medical-IP structuring opportunity for Jersey's funds industry. £450M–£1.7B a year at maturity — about 8–31% of current island GVA.

Read the numbers →
04 / Infrastructure

Island infrastructure

What Jersey needs to build — software, data and clinical infrastructure — to make the framework operational. Starting with the Overdale hospital IT specification decisions being made now.

Read what's needed →
05 / Highlands

The Highlands consideration

A separate, further-out possibility: the Highlands College campus becoming a dedicated medical research facility once the hospital and college moves play out. Sketched, not sold.

Read the sketch →
06 / Timeline

The phasing

From a first States motion to a mature framework in six indicative steps — and the three decision gates where legislation, regulator capacity and physical infrastructure need to meet.

See the timeline →
A note on tone

This site is a working brief, not a manifesto. Where a claim is speculative it is marked as such. Where a figure or timeline is directional rather than committed, it is marked directional.